GSK1324726A

BRD2:41 nM|BRD3:31 nM|BRD4:22 nM

在神经母细胞瘤细胞系中,GSK1324726A抑制细胞生长并诱导细胞毒性。GSK1324726A能够调节MYC家族通路的基因表达,包括BCL2 和 MYCN的直接表达。

在小鼠SK-N-AS和CHP-212模型中, GSK1324726A（15 mg/kg o.p.）抑制肿瘤生长,并下调MYCN 和 BCL2的表达.在小鼠感染性休克模型中,GSK1324726A（10 mg/kg i.v. ）表现出有效的抗炎作用,并防止患病动物的死亡.

DMSO:80 mg/mL (183.9 mM),H2O:<1 mg/mL,Ethanol:80 mg/mL (183.9 mM)

Briefly, cells are seeded into 384-well or 96-well plates at a density optimized for 6 days of growth. The following day, T0 measurements are taken using CellTiter-Glo, CellTiter-Fluor, or CyQuant Direct, following the manufacturer's instructions. Plates are read on an Envision, Safire 2, or SpectraMax Gemini EM plate reader. Remaining plates are treated with DMSO or a titration of I-BET726. Cells are incubated for 6 days and developed as described above. Results are plotted as a percentage of the T0 value, normalized to 100%, versus concentration of compound. A 4-parameter equation is used to generate concentration response curves. Growth IC50 (gIC50) values are calculated at the mid-point of the growth window (between DMSO and T0 values). Ymin-T0 values are calculated by subtracting the T0 value (100%) from the Ymin value on the curve, and are a measure of net population cell growth or death.(Only for Reference)